Dopaminergic system in CA1 modulates MK-801 induced anxiolytic-like responses

Pharmacology Biochemistry and Behavior

Volumn 103, Issue 1, 2012, Pages 102-110

  Zarrindast, Mohammad Reza ^a,c,d,e,f   Nasehi, Mohammad ^b   Pournaghshband, Mahnaz ^b,c   Ghorbani Yekta, Batool ^g  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e INSTITUTE FOR RESEARCH IN FUNDAMENTAL SCIENCES IPM   (Iran)

^f INSTITUTE FOR COGNITIVE SCIENCE STUDIES ICSS   (Iran)

^g ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Anxiolytic like response; Dorsal hippocampus (CA1); Elevated plus maze; MK801; Rat(s); SCH23390; Sulpiride

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DIZOCILPINE; SULPIRIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; CONTROLLED STUDY; DEFECATION; DOPAMINERGIC SYSTEM; EXPLORATORY BEHAVIOR; GROOMING; HIPPOCAMPAL CA1 REGION; LOCOMOTION; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; REARING; TRANQUILIZING ACTIVITY; TREATMENT RESPONSE;

ANIMALS; ANXIETY; BENZAZEPINES; CA1 REGION, HIPPOCAMPAL; DIZOCILPINE MALEATE; DOPAMINE; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MAZE LEARNING; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, N-METHYL-D-ASPARTATE; SULPIRIDE;

RATTUS; RATTUS NORVEGICUS;

EID: 84865570214     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2012.07.016     Document Type: Article

References (98)

1. W. Adriani, A. Felici, F. Sargolini, P. Roullet, A. Usiello, and A. Oliverio N-methyl-D-aspartate and dopamine receptor involvement in the modulation of locomotor activity and memory processes Exp Brain Res 123 1998 52 59
2. D.M. Bannerman, M. Grubb, R.M. Deacon, B.K. Yee, J. Feldon, and J.N. Rawlins Ventral hippocampal lesions affect anxiety but not spatial learning Behav Brain Res 139 2003 197 213
3. C. Barkus, S.B. McHugh, R. Sprengel, P.H. Seeburg, J.N. Rawlins, and D.M. Bannerman Hippocampal NMDA receptors and anxiety: at the interface between cognition and emotion Eur J Pharmacol 626 2009 49 56
4. C. Barkus, S.B. McHugh, R. Sprengel, P.H. Seeburg, J.N. Rawlins, and D.M. Bannerman Hippocampal NMDA receptors and anxiety: at the interface between cognition and emotion Eur J Pharmacol 626 2010 49 56
5. C. Barkus, S.B. McHugh, R. Sprengel, P.H. Seeburg, J.N. Rawlins, and D.M. Bannerman Hippocampal NMDA receptors and anxiety: at the interface between cognition and emotion Eur J Pharmacol 626 2010 49 56
6. M.A. Beazely, A. Tong, W.L. Wei, H. Van Tol, B. Sidhu, and J.F. MacDonald D2-class dopamine receptor inhibition of NMDA currents in prefrontal cortical neurons is platelet-derived growth factor receptor-dependent J Neurochem 98 2006 1657 1663
7. G.A. Behr, L.L. da Motta, M.R. de Oliveira, M.W. Oliveira, M.L. Hoff, and R.B. Silvestrin Decreased anxiety-like behavior and locomotor/exploratory activity, and modulation in hypothalamus, hippocampus, and frontal cortex redox profile in sexually receptive female rats after short-term exposure to male chemical cues Behav Brain Res 199 2009 263 270
8. J.M. Boyce-Rustay, and A. Holmes Genetic inactivation of the NMDA receptor NR2A subunit has anxiolytic- and antidepressant-like effects in mice Neuropsychopharmacology 31 2006 2405 2414
9. S. Cabib, E. Kempf, C. Schleef, A. Oliverio, and S. Puglisi-Allegra Effects of immobilization stress on dopamine and its metabolites in different brain areas of the mouse: role of genotype and stress duration Brain Res 441 1988 153 160
10. A. Carlsson, N. Waters, and M.L. Carlsson Neurotransmitter interactions in schizophrenia-therapeutic implications Eur Arch Psychiatry Clin Neurosci 249 1999 37 43
11. M. Casarrubea, F. Sorbera, and G. Crescimanno Structure of rat behavior in hole-board: I) multivariate analysis of response to anxiety Physiol Behav 96 2009 174 179
12. C. Cepeda, N.A. Buchwald, and M.S. Levine Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated Proc Natl Acad Sci 90 1993 9576
13. Y. Chen, U. Beffert, M. Ertunc, T.S. Tang, E.T. Kavalali, and I. Bezprozvanny Reelin modulates NMDA receptor activity in cortical neurons J Neurosci 25 2005 8209
14. O. Civelli, J.R. Bunzow, and D.K. Grandy Molecular diversity of the dopamine receptors Annu Rev Pharmacol Toxicol 33 1993 281 307
15. J.C. Cole, and R.J. Rodgers An ethological analysis of the effects of chlordiazepoxide and bretazenil (Ro 16-6028) in the murine elevated plus-maze Behav Pharmacol 4 1993 573 580
16. A.P. Cruz, F. Frei, and F.G. Graeff Ethopharmacological analysis of rat behavior on the elevated plus-maze Pharmacol Biochem Behav 49 1994 171 176
17. R. Dall'Olio, O. Gandolfi, and N. Montanaro Effect of chronic treatment with dizocilpine (MK-801) on the behavioral response to dopamine receptor agonists in the rat Psychopharmacology 107 1992 591 594
18. M. Davis, W.A. Falls, S. Campeau, and M. Kim Fear-potentiated startle: a neural and pharmacological analysis Behav Brain Res 58 1993 175 198
19. M.P. de la Mora, A. Gallegos-Cari, Y. Arizmendi-Garcia, D. Marcellino, and K. Fuxe Role of dopamine receptor mechanisms in the amygdaloid modulation of fear and anxiety: structural and functional analysis Prog Neurobiol 90 2010 198 216
20. A.Y. Deutch, S.Y. Tam, and R.H. Roth Footshock and conditioned stress increase 3,4-dihydroxyphenylacetic acid (DOPAC) in the ventral tegmental area but not substantia nigra Brain Res 333 1985 143 146
21. G. Diana, and S. Sagratella Different capability of N-methyl-D-aspartate antagonists to affect locomotor/exploratory activity of mice in a computerized on-line open field test Pharmacol Biochem Behav 48 1994 291 295
22. A.J. Dunn Stress-related activation of cerebral dopaminergic systems Ann N Y Acad Sci 537 1988 188 205
23. R.W. Dunn, R. Corbett, and S. Fielding Effects of 5-HT1A receptor agonists and NMDA receptor antagonists in the social interaction test and the elevated plus maze Eur J Pharmacol 169 1989 1 10
24. D. Eslimi, S. Oryan, M. Nasehi, and M.R. Zarrindast Effects of opioidergic systems upon anxiolytic-like behaviors induced in cholestatic rats Eur J Pharmacol 670 2011 180 185
25. M.G. Feenstra, M.H. Botterblom, and J.F. van Uum Local activation of metabotropic glutamate receptors inhibits the handling-induced increased release of dopamine in the nucleus accumbens but not that of dopamine or noradrenaline in the prefrontal cortex: comparison with inhibition of ionotropic receptors J Neurochem 70 1998 1104 1113
26. E.I. Flandreau, K.J. Ressler, M.J. Owens, and C.B. Nemeroff Chronic overexpression of corticotropin-releasing factor from the central amygdala produces HPA axis hyperactivity and behavioral anxiety associated with gene-expression changes in the hippocampus and paraventricular nucleus of the hypothalamus Psychoneuroendocrinology 37 2012 27 38
27. D. Forestiero, C.M. Manfrim, F.S. Guimaraes, and R.M. de Oliveira Anxiolytic-like effects induced by nitric oxide synthase inhibitors microinjected into the medial amygdala of rats Psychopharmacology (Berl) 184 2006 166 172
28. E.D. French, K. Dillon, and X. Wu Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra Neuroreport 8 1997 649
29. A.E. Gadalla, T. Pearson, A.J. Currie, N. Dale, S.A. Hawley, and M. Sheehan AICA riboside both activates AMP-activated protein kinase and competes with adenosine for the nucleoside transporter in the CA1 region of the rat hippocampus J Neurochem 88 2004 1272 1282
30. A.M. Garcia, R. Martinez, M.L. Brandao, and S. Morato Effects of apomorphine on rat behavior in the elevated plus-maze Physiol Behav 85 2005 440 447
31. J.A. Gingrich, and M.G. Caron Recent advances in the molecular biology of dopamine receptors Annu Rev Neurosci 16 1993 299 321
32. L.E. Goldstein, A.M. Rasmusson, B.S. Bunney, and R.H. Roth The NMDA glycine site antagonist (+)-HA-966 selectively regulates conditioned stress-induced metabolic activation of the mesoprefrontal cortical dopamine but not serotonin systems: a behavioral, neuroendocrine, and neurochemical study in the rat J Neurosci 14 1994 4937 4950
33. C. Gonzalez-Islas, and J.J. Hablitz Dopamine enhances EPSCs in layer II-III pyramidal neurons in rat prefrontal cortex J Neurosci 23 2003 867
34. Q. Greba, and L. Kokkinidis Peripheral and intraamygdalar administration of the dopamine D1 receptor antagonist SCH 23390 blocks fear-potentiated startle but not shock reactivity or the shock sensitization of acoustic startle Behav Neurosci 114 2000 262 272
35. Y. Guo, H.L. Wang, X.H. Xiang, and Y. Zhao The role of glutamate and its receptors in mesocorticolimbic dopaminergic regions in opioid addiction Neurosci Biobehav Rev 33 2009 864 873
36. H. Gurden, M. Takita, and T.M. Jay Essential role of D1 but not D2 receptors in the NMDA receptor-dependent long-term potentiation at hippocampal-prefrontal cortex synapses in vivo J Neurosci 106 2000
37. P.G. Henke Hippocampal pathway to the amygdala and stress ulcer development Brain Res Bull 25 1990 691 695
38. J.P. Herman, W.E. Cullinan, E.A. Young, H. Akil, and S.J. Watson Selective forebrain fiber tract lesions implicate ventral hippocampal structures in tonic regulation of paraventricular nucleus corticotropin-releasing hormone (CRH) and arginine vasopressin (AVP) mRNA expression Brain Res 592 1992 228 238
39. J.P. Herman, W.E. Cullinan, M.I. Morano, H. Akil, and S.J. Watson Contribution of the ventral subiculum to inhibitory regulation of the hypothalamo-pituitary-adrenocortical axis J Neuroendocrinol 7 1995 475 482
40. M.R. Hunsaker, G.T. Tran, and R.P. Kesner A double dissociation of subcortical hippocampal efferents for encoding and consolidation/retrieval of spatial information Hippocampus 18 2008 699 709
41. A. Imperato, S. Puglisi-Allegra, A. Zocchi, M.G. Scrocco, P. Casolini, and L. Angelucci Stress activation of limbic and cortical dopamine release is prevented by ICS 205-930 but not by diazepam Eur J Pharmacol 175 1990 211 214
42. T. Inoue, T. Izumi, Y. Maki, I. Muraki, and T. Koyama Effect of the dopamine D(1/5) antagonist SCH 23390 on the acquisition of conditioned fear Pharmacol Biochem Behav 66 2000 573 578
43. L. Jacobsen, and R. Sapolsky The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis Endocr Rev 12 1991
44. N. Jamali-Raeufy, M. Nasehi, and M.R. Zarrindast Influence of N-methyl D-aspartate receptor mechanism on WIN55, 212-2-induced amnesia in rat dorsal hippocampus Behav Pharmacol 22 2011 645 654
45. A.V. Kalueff, Y.R. Lou, I. Laaksi, and P. Tuohimaa Increased grooming behavior in mice lacking vitamin D receptors Physiol Behav 82 2004 405 409
46. S.A. Kotecha, J.N. Oak, M.F. Jackson, Y. Perez, B.A. Orser, and H.H. Van Tol A D2 class dopamine receptor transactivates a receptor tyrosine kinase to inhibit NMDA receptor transmission Neuron 35 2002 1111 1122
47. S. Liljequist, K. Ossowska, M. Grabowska-Andén, and N.E. Andén Effect of the NMDA receptor antagonist, MK-801, on locomotor activity and on the metabolism of dopamine in various brain areas of mice Eur J Pharmacol 195 1991 55 61
48. J.L. Liu, M. Li, X.R. Dang, Z.H. Wang, Z.R. Rao, and S.X. Wu A NMDA receptor antagonist, MK-801 impairs consolidating extinction of auditory conditioned fear responses in a Pavlovian model PLoS One 4 2009 e7548
49. A. Louilot, M. Le Moal, and H. Simon Differential reactivity of dopaminergic neurons in the nucleus accumbens in response to different behavioral situations. An in vivo voltammetric study in free moving rats Brain Res 397 1986 395 400
50. S.B. McHugh, B. Niewoehner, J.N. Rawlins, and D.M. Bannerman Dorsal hippocampal N-methyl-D-aspartate receptors underlie spatial working memory performance during non-matching to place testing on the T-maze Behav Brain Res 186 2008 41 47
51. A. Mele, C. Castellano, A. Felici, S. Cabib, S. Caccia, and A. Oliverio Dopamine-N-methyl-aspartate interactions in the modulation of locomotor activity and memory consolidation in mice* 1 Eur J Pharmacol 308 1996 1 12
52. T.T. Miguel, and R.L. Nunes-de-Souza Anxiogenic-like effects induced by NMDA receptor activation are prevented by inhibition of neuronal nitric oxide synthase in the periaqueductal gray in mice Brain Res 1240 2008 39 46
53. M. Minlebaev, Y. Ben-Ari, and R. Khazipov NMDA receptors pattern early activity in the developing barrel cortex in vivo Cereb Cortex 19 2009 688 696
54. C. Missale, S.R. Nash, S.W. Robinson, M. Jaber, and M.G. Caron Dopamine receptors: from structure to function Physiol Rev 78 1998 189 225
55. B.G. Mockett, D. Guevremont, J.M. Williams, and W.C. Abraham Dopamine D1/D5 receptor activation reverses NMDA receptor-dependent long-term depression in rat hippocampus J Neurosci 27 2007 2918 2926
56. B.A. Morrow, J.D. Elsworth, C. Zito, and R.H. Roth Biochemical and behavioral anxiolytic-like effects of R(+)HA-966 at the level of the ventral tegmental area in rats Psychopharmacology (Berl) 143 1999 227 234
57. L.P. Nascimento Hackl, and A.P. Carobrez Distinct ventral and dorsal hippocampus AP5 anxiolytic effects revealed in the elevated plus-maze task in rats Neurobiol Learn Mem 88 2007 177 185
58. M. Nasehi, F. Mafi, S. Oryan, S. Nasri, and M.R. Zarrindast The effects of dopaminergic drugs in the dorsal hippocampus of mice in the nicotine-induced anxiogenic-like response Pharmacol Biochem Behav 98 2011 468 473
59. M.F. O'Neill, and G. Shaw Comparison of dopamine receptor antagonists on hyperlocomotion induced by cocaine, amphetamine, MK-801 and the dopamine D1 agonist C-APB in mice Psychopharmacology 145 1999 237 250
60. C.M. O'Carroll, and R.G. Morris Heterosynaptic co-activation of glutamatergic and dopaminergic afferents is required to induce persistent long-term potentiation Neuropharmacology 47 2004 324 332
61. A. Ouagazzal, A. Nieoullon, and M. Amalric Effects of dopamine D1 and D2 receptor blockade on MK-801-induced hyperlocomotion in rats Psychopharmacology 111 1993 427 434
62. C.M. Padovan, and F.S. Guimaraes Restraint-induced hypoactivity in an elevated plus-maze Braz J Med Biol Res 33 2000 79 83
63. C.M. Padovan, E.A. Del Bel, and F.S. Guimaraes Behavioral effects in the elevated plus maze of an NMDA antagonist injected into the dorsal hippocampus: influence of restraint stress Pharmacol Biochem Behav 67 2000 325 330
64. G. Paxinos, and C. Watson The rat brain in stereotaxic coordinates 6th ed. 2007 Academic Press London.UK
65. A. Plaznik, W. Palejko, M. Nazar, and M. Jessa Effects of antagonists at the NMDA receptor complex in two models of anxiety Eur Neuropsychopharmacol 4 1994 503 512
66. E. Przegalinski, E. Tatarczynska, and E. Chojnacka-Wojcik The influence of the benzodiazepine receptor antagonist flumazenil on the anxiolytic-like effects of CGP 37849 and ACPC in rats Neuropharmacology 39 2000 1858 1864
67. S. Puglisi-Allegra, A. Imperato, L. Angelucci, and S. Cabib Acute stress induces time-dependent responses in dopamine mesolimbic system Brain Res 554 1991 217 222
68. J.F. Reinhard Jr., M.J. Bannon, and R.H. Roth Acceleration by stress of dopamine synthesis and metabolism in prefrontal cortex: antagonism by diazepam Naunyn Schmiedebergs Arch Pharmacol 318 1982 374 377
69. F.L. Reis, S. Masson, A.R. de Oliveira, and M.L. Brandao Dopaminergic mechanisms in the conditioned and unconditioned fear as assessed by the two-way avoidance and light switch-off tests Pharmacol Biochem Behav 79 2004 359 365
70. M. Rezvanfard, M.R. Zarrindast, and P. Bina Role of ventral hippocampal GABA(A) and NMDA receptors in the anxiolytic effect of carbamazepine in rats using the elevated plus maze test Pharmacology 84 2009 356 366
71. R.J. Rodgers, E.M. Nikulina, and J.C. Cole Dopamine D1 and D2 receptor ligands modulate the behaviour of mice in the elevated plus-maze Pharmacol Biochem Behav 49 1994 985 995
72. A. Roohbakhsh, S. Keshavarz, P. Hasanein, M.E. Rezvani, and A.H. Moghaddam Role of endocannabinoid system in the ventral hippocampus of rats in the modulation of anxiety-like behaviours Basic Clin Pharmacol Toxicol 105 2009 333 338
73. P. Rostami, A. Hajizadeh-Moghaddam, and M.R. Zarrindast The effects of histaminergic agents in the ventral hippocampus of rats in the plus-maze test of anxiety-like behaviours Physiol Behav 87 2006 891 896
74. K. Sarantis, N. Matsokis, and F. Angelatou Synergistic interactions of dopamine D1 and glutamate NMDA receptors in rat hippocampus and prefrontal cortex: involvement of ERK1/2 signaling Neuroscience 163 2009 1135 1145
75. F.R. Schneier, A. Abi-Dargham, D. Martinez, M. Slifstein, D.R. Hwang, and M.R. Liebowitz Dopamine transporters, D2 receptors, and dopamine release in generalized social anxiety disorder Depress Anxiety 26 2009 411 418
76. S.C. Sealfon, and C.W. Olanow Dopamine receptors: from structure to behavior Trends Neurosci 23 2000 S34 S40
77. P. Seeman, and H.H. Van Tol Dopamine receptor pharmacology Curr Opin Neurol Neurosurg 6 1993 602 608
78. A.A. Shah, T. Sjovold, and D. Treit Selective antagonism of medial prefrontal cortex D4 receptors decreases fear-related behaviour in rats Eur J Neurosci 19 2004 3393 3397
79. A.C. Sharma, and S.K. Kulkarni Evidence for benzodiazepine receptor interaction with MK 801 in anxiety related behaviour in rats Indian J Exp Biol 31 1993 191 193
80. A. Simonyi, T.R. Schachtman, and G.R. Christoffersen Metabotropic glutamate receptor subtype 5 antagonism in learning and memory Eur J Pharmacol 639 2010 17 25
81. Q.J. Sun, R.S. Duan, A.H. Wang, W. Shang, T. Zhang, and X.Q. Zhang Alterations of NR2B and PSD-95 expression in hippocampus of kainic acid-exposed rats with behavioural deficits Behav Brain Res 201 2009 292 299
82. L.W. Swanson, and W.M. Cowan An autoradiographic study of the organization of the efferent connections of the hippocampal formation in the rat J Comp Neurol 172 1977 49 84
83. J.M. Tepper, B.C. Sun, L.P. Martin, and I. Creese Functional roles of dopamine D2 and D3 autoreceptors on nigrostriatal neurons analyzed by antisense knockdown in vivo J Neurosci 17 1997 2519
84. C. Timothy, B. Costall, and J.W. Smythe Effects of SCH23390 and raclopride on anxiety-like behavior in rats tested in the black-white box Pharmacol Biochem Behav 62 1999 323 327
85. L.L. Tonetto, A.L. Terzian, E.A. Del Bel, F.S. Guimaraes, and L.B. Resstel Inhibition of the NMDA receptor/nitric oxide pathway in the dorsolateral periaqueductal gray causes anxiolytic-like effects in rats submitted to the Vogel conflict test Behav Brain Funct 5 2009 40
86. K.Y. Tseng, and P. O'Donnell Dopamine-glutamate interactions controlling prefrontal cortical pyramidal cell excitability involve multiple signaling mechanisms J Neurosci 24 2004 5131
87. T. van Groen, and J.M. Wyss Extrinsic projections from area CA1 of the rat hippocampus: olfactory, cortical, subcortical, and bilateral hippocampal formation projections J Comp Neurol 302 1990 515 528
88. A.A. Walf, and C.A. Frye A review and update of mechanisms of estrogen in the hippocampus and amygdala for anxiety and depression behavior Neuropsychopharmacology 31 2006 1097 1111
89. J. Wang, and P. O'Donnell D1 dopamine receptors potentiate NMDA-mediated excitability increase in layer V prefrontal cortical pyramidal neurons Cereb Cortex 11 2001 452
90. J.M. Wyss, L.W. Swanson, and W.M. Cowan The organization of the fimbria, dorsal fornix and ventral hippocampal commissure in the rat Anat Embryol (Berl) 158 1980 303 316
91. Y.F. Xie, F.Q. Huo, and J.S. Tang Cerebral cortex modulation of pain Acta Pharmacol Sin 30 2009 31 41
92. A.V. Yarkov, T.C. Der, and J.N. Joyce Locomotor activity induced by MK-801 is enhanced in dopamine D3 receptor knockout mice but suppression by dopamine D3/D2 antagonists does not occur through the dopamine D3 receptor Eur J Pharmacol 627 2010 167 172
93. M.R. Zarrindast, M. Torabi, P. Rostami, and S. Fazli-Tabaei The effects of histaminergic agents in the dorsal hippocampus of rats in the elevated plus-maze test of anxiety Pharmacol Biochem Behav 85 2006 500 506
94. M.R. Zarrindast, S. Sarahroodi, A. Arzi, M.J. Khodayar, S. Taheri-Shalmani, and A. Rezayof Cannabinoid CB1 receptors of the rat central amygdala mediate anxiety-like behavior: interaction with the opioid system Behav Pharmacol 19 2008 716 723
95. M.R. Zarrindast, J. Solati, S. Oryan, and K. Parivar Effect of intra-amygdala injection of nicotine and GABA receptor agents on anxiety-like behaviour in rats Pharmacology 82 2008 276 284
96. M.R. Zarrindast, N. Naghdi-Sedeh, M. Nasehi, H. Sahraei, F. Bahrami, and F. Asadi The effects of dopaminergic drugs in the ventral hippocampus of rats in the nicotine-induced anxiogenic-like response Neurosci Lett 475 2010 156 160
97. M.R. Zarrindast, M. Nasehi, M. Piri, and N. Heidari Effects of cholinergic system of dorsal hippocampus of rats on MK-801 induced anxiolytic-like behavior Neurosci Lett 505 2011 65 70
98. L.S. Zweifel, J.P. Fadok, E. Argilli, M.G. Garelick, G.L. Jones, and T.M. Dickerson Activation of dopamine neurons is critical for aversive conditioning and prevention of generalized anxiety Nat Neurosci 14 2011 620 626